HI
SNOA icon

Harbour Investments’s Sonoma Pharmaceuticals SNOA Stock Holding History

Harbour Investments’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18 Buy
+15
New +$21 ﹤0.01% 4724

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
QWM
Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return

Harbour Investments's SNOA Position: Q2 2026 in Review

Harbour Investments opened a new position in Sonoma Pharmaceuticals (SNOA) in Q2 2026: 15 shares worth $18. The stake represents ﹤0.01% of the portfolio and ranks #4724 among its holdings.

12 funds tracked by Wall St. Rank hold SNOA as of Q2 2026.

  • Harbour Investments held 15 shares of Sonoma Pharmaceuticals worth $18 as of Q2 2026.
  • Sonoma Pharmaceuticals was a new Harbour Investments position in Q2 2026.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4724 holding.
  • 12 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.